New collagen injection aims to smooth wrinkles and restore facial volume
NCT ID NCT07413445
First seen Feb 25, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This study tests the safety and performance of an injectable collagen product called MEC REGENERATE® for treating wrinkles and volume loss in the mid-face. Twenty adults aged 35-65 will receive a single injection and be monitored for 60 days. The main goals are to check for side effects and measure improvements in skin hydration and wrinkle severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico
Genova, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.